US Drug Recall Register
Class II · Moderate risk Terminated Initiated Oct 9, 2019 (7 years ago)

PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

GMP Deviations: potential glass contamination

What was recalled

PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25

Recalling firm
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
NDC code
69374-0525-25
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0147-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all